Clinical Trials Browser

Unknown × Etoposide × Lymphoid × Clear all

NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT03576378 2024-02-26

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Phase 1/2 Unknown

Hodgkin Disease

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT03077828 2023-06-02

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Unknown

43 enrolled 9 charts

Hodgkin Disease

NCT05863845 2023-05-18

Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL

Phase NA Unknown

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04981899 2023-04-12

NICE-40

Phase 1/2 Unknown

Hodgkin Disease

NCT05784987 2023-03-27

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase NA Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05776407 2023-03-20

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Phase 1/2 Unknown

Lymphoma, B-Cell

NCT05774028 2023-03-17

Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT03467256 2023-02-24

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05466318 2022-07-25

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Phase 3 Unknown

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03736616 2022-07-22

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Phase 1 Unknown

Burkitt Lymphoma, Lymphoma, B-Cell

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Phase 1/2 Unknown

38 enrolled 12 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03837873 2022-01-26

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT03629873 2022-01-03

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell

NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Phase 2 Unknown

Burkitt Lymphoma

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02631239 2021-08-25

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Phase 3 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT04999878 2021-08-11

RUE-DDGP

Phase 4 Unknown

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT00324467 2021-07-22

LYTPET

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT04917250 2021-06-08

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT04679506 2020-12-22

the Efficacy and Safety of CLAE in R/R T-ALL/LBL

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02544425 2020-10-22

VIDL+ASCT

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Phase 2 Unknown

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04038411 2019-07-30

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

Phase 2 Unknown

LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

NCT03623087 2018-08-14

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Phase 3 Unknown

Lymphoma, Non-Hodgkin, Recurrence

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03071822 2018-06-11

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral

NCT03315520 2018-05-22

BeEAC-1

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT03383406 2017-12-26

IVAM

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Phase 4 Unknown

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

NCT03154918 2017-11-08

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT03321890 2017-10-26

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT03229616 2017-10-12

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Phase 2/3 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT03018626 2017-07-28

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT02987244 2016-12-08

Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

Phase 1/2 Unknown

Lymphoma, T-Cell

NCT02836639 2016-07-19

BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00795613 2015-10-19

HD0607

Phase 2 Unknown

Hodgkin Disease

NCT01873807 2015-10-09

HITA

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01423500 2015-06-26

ALL-SCT-BFMi

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01423747 2015-06-26

Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01178645 2014-08-25

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT01178658 2014-08-25

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00003423 2013-12-19

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Phase 3 Unknown

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00002481 2013-12-18

Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma